株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ブルセラ症(波状熱):世界の治験動向

Brucellosis Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 350887
出版日 ページ情報 英文 39 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.05円で換算しております。
Back to Top
ブルセラ症(波状熱):世界の治験動向 Brucellosis Global Clinical Trials Review, H1, 2017
出版日: 2017年05月31日 ページ情報: 英文 39 Pages
概要

当レポートでは、ブルセラ症(波状熱)に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、E7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; 欧州
    • 主要国における治験件数; 中東/アフリカ地域

E7諸国における治験件数:ブルセラ症(波状熱)治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

有望な薬剤

治験プロファイルの基本情報

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Brucellosis Global Clinical Trials Review, H1, 2017" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Brucellosis to Infectious Disease Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials by E7 Countries: Proportion of Brucellosis to Infectious Disease Clinical Trials 16
  • Clinical Trials by Phase 17
  • Clinical Trials by Trial Status 18
  • Clinical Trials by End Point Status 19
  • Subjects Recruited Over a Period of Time 20
  • Clinical Trials by Sponsor Type 21
  • Prominent Sponsors 22
  • Top Companies Participating in Brucellosis Therapeutics Clinical Trials 23
  • Prominent Drugs 24
  • Clinical Trial Profile Snapshots 25

Appendix 36

  • Abbreviations 36
  • Definitions 36
  • Research Methodology 37
  • Secondary Research 37
  • About GlobalData 38
  • Contact Us 38
  • Source 39

List of Tables

List of Tables

  • Brucellosis Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Brucellosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Brucellosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Brucellosis Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11
  • Brucellosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Brucellosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Brucellosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14
  • Brucellosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Proportion of Brucellosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 16
  • Brucellosis Therapeutics, Global, Clinical Trials by Phase, 2017* 17
  • Brucellosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
  • Brucellosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
  • Brucellosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
  • Brucellosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 21
  • Brucellosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
  • Brucellosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 23
  • Brucellosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 24

List of Figures

List of Figures

  • Brucellosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Brucellosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Brucellosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11
  • Brucellosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Brucellosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Proportion of Brucellosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14
  • Brucellosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Proportion of Brucellosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 16
  • Brucellosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
  • Brucellosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 18
  • Brucellosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 19
  • Brucellosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 20
  • Brucellosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 21
  • Brucellosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 22
  • Brucellosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 23
  • Brucellosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 24
  • GlobalData Methodology 37
Back to Top